Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial With Ferric Maltol Capsules for the Treatment of Iron Deficiency Anemia in Subjects With Inflammatory Bowel Disease and Refractory/Intolerant to Oral Ferrous Preparations

NCT07739368 is registered in ClinicalTrials.gov with Jiangsu Aosaikang Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07739368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07739368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial With Ferric Maltol Capsules for the Treatment of Iron Deficiency Anemia in Subjects With Inflammatory Bowel Disease and Refractory/Intolerant to Oral Ferrous Preparations
Lead sponsor
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
September 1, 2021
Completion date
March 20, 2025
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anaemia